Neurofunctional dopaminergic impairment in elderly after lifetime exposure to manganese

Roberto G Lucchini1, Stefano Guazzetti2, Silvia Zoni3

  • 1Occupational Health, University of Brescia, Italy; Preventive Medicine, Mount Sinai School of Medicine, NY, USA; Microbiology and Environmental Toxicology, University of California, Santa Cruz, USA.

Neurotoxicology
|June 3, 2014
PubMed
Abstract

Insights

Long-term manganese (Mn) exposure in elderly individuals was linked to neurocognitive and motor function deficits. Co-exposure to lead (Pb) may exacerbate these manganese-induced effects, highlighting environmental health concerns.

Area of Science:

  • Environmental Health
  • Neurotoxicology
  • Gerontology

Background:

  • Manganese (Mn) is essential but can be neurotoxic, particularly in the elderly with compromised physiology.
  • Historical ferroalloy plant emissions in Valcamonica, Italy, led to environmental manganese and lead (Pb) contamination.
  • Previous observations noted a high prevalence of Parkinsonism in the Mn-exposed area.

Purpose of the Study:

  • To assess neurocognitive and motor functions in elderly residents of a Mn-exposed area (Valcamonica) compared to a reference area.
  • To investigate dose-response relationships between Mn and Pb exposure and neurological outcomes.
  • To evaluate the role of age as an effect modifier in Mn neurotoxicity.

Main Methods:

  • Neurobehavioral assessments of motor, cognitive, and sensory functions were performed on 255 elderly subjects.
  • Exposure assessment included air sampling (PM10), soil and water analysis, and blood/urine Mn and Pb levels.
  • Generalized Additive Models (GAM) were used to analyze exposure-biomarker-health outcome relationships.

Main Results:

  • Airborne Mn was associated with impaired motor coordination (p=0.0237).
  • Soil Mn correlated with reduced odor identification (p=0.0006) and cognitive function (p=0.09).
  • Urinary Mn linked to cognitive deficits (p=0.0074), and serum prolactin (PRL) levels associated with Mn and Pb exposure (p<0.061).

Conclusions:

  • Lifelong manganese exposure is significantly associated with olfactory, motor, and cognitive impairments in the elderly.
  • These findings support Mn's specific toxicity to the dopaminergic system.
  • Even low-level lead co-exposure can potentiate manganese neurotoxicity.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
21
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
366
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31